Mind Medicine (MindMed) (MNMD) has quietly turned into one of the stronger movers in psychedelic drug development this year, with the stock up roughly 66% year to date and nearly 4x over the past 3 ...

If you are wondering whether Mineralys Therapeutics is still worth buying after its big run, you are not alone. This is exactly what we are going to unpack. The stock has pulled back about 12.1% over ...

Flagstar Bank appears well-positioned to reaffirm its 2026 outlook, supported by accelerating C&I growth and targeted CRE originations. Multifamily loan resets and declining funding costs should lift ...

Learn how discounted after-tax cash flow helps evaluate real estate investments by factoring in taxes and determining profitability, essential for investment decisions.

Wealthfront Corporation is rated a Buy due to reasonable valuation, high insider ownership, & strong product-market fit. Read ...

Advice on what schools (and parents) can do to help their Year 11 students navigate the crucial final year of their ...

Lumentum’s leadership in optical and photonic technologies positions it to capitalize on surging AI, cloud, and telecom ...

Scholastic Corp (SCHL) reports robust earnings growth, driven by successful book fairs and strategic sale-leaseback ...

KB Home (KBH) reports robust financial performance with strategic focus on build-to-order sales and community expansion, despite facing pricing pressures and market constraints.

Q1 2026 Earnings Call Transcript December 18, 2025 Accenture plc beats earnings expectations. Reported EPS is $3.94, expectations were $3.74. Operator: Good morning. Thank you for standing by. Welcome ...

January 2026 arrives with a array of changes across France and Île-de-France. Fare increases for the Navigo pass, an increase in the minimum wage, the suspension of MaPrimeRénov', and stricter ...